U.S. markets open in 6 hours 18 minutes

Tetra Bio-Pharma Inc. (TBP.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.1950+0.0350 (+21.87%)
At close: 3:59PM EST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.1600
Open0.1650
Bid0.1950 x N/A
Ask0.2000 x N/A
Day's Range0.1650 - 0.2100
52 Week Range0.1350 - 0.3700
Volume15,503,328
Avg. Volume1,574,138
Market Cap69.901M
Beta (5Y Monthly)1.93
PE Ratio (TTM)N/A
EPS (TTM)-0.1030
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Correction To Tetra Bio-Pharma News Release Dated February 25th
      ACCESSWIRE

      Correction To Tetra Bio-Pharma News Release Dated February 25th

      OTTAWA, ON / ACCESSWIRE / March 8, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company")(TSX: TBP)(OTCQB: TBPMF), a biopharmaceutical pioneer in immunomodulator drug discovery and development wishes to make the following correction to its news release dated February 25th, 2021.

    • Tetra Bio-Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
      ACCESSWIRE

      Tetra Bio-Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

      OTTAWA, ON / ACCESSWIRE / March 3, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company")(TSX:TBP)(OTCQB:TBPMF), a biopharmaceutical pioneer in immunomodulator drug discovery and development announces that CEO Dr.

    • Tetra Bio-Pharma Announces Closing of Bought Deal Offering
      CNW Group

      Tetra Bio-Pharma Announces Closing of Bought Deal Offering

      /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/OTTAWA, ON, March 2, 2021 /CNW Telbec/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF), a biopharmaceutical pioneer in immunomodulator drug discovery and development, is pleased to announce it has closed its previously announced bought-deal public offering of units (the "Units") of the Company.